Erratum to “Scrapie-infected GT1-1 cells show impaired function of voltage-gated N-type calcium channels (Cav 2.2) which is ameliorated by quinacrine treatment” [Neurobiol. Dis. 15 (2004) 143–151]

Erratum to “Scrapie-infected GT1-1 cells show impaired function of voltage-gated N-type calcium channels (Cav 2.2) which is ameliorated by quinacrine treatment” [Neurobiol. Dis. 15 (2004) 143–151]

Bibliographic Details
Main Authors:	Malin K. Sandberg, Peter Wallén, Martin A. Wikström, Krister Kristensson
Format:	Article
Language:	English
Published:	Elsevier 2004-07-01
Series:	Neurobiology of Disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S096999610400083X

Similar Items

Scrapie-infected GT1-1 cells show impaired function of voltage-gated N-type calcium channels (Cav 2.2) which is ameliorated by quinacrine treatment
by: Malin K Sandberg, et al.
Published: (2004-02-01)

ACAT-1, Cav-1 and PrP expression in scrapie susceptible and resistant sheep
by: Orrù Cristina, et al.
Published: (2010-02-01)

Erratum to “CXCL12/SDF-1 facilitates optic nerve regeneration” [Neurobiol. Dis. 55 (2013) 76–86]
by: Annemarie Heskamp, et al.
Published: (2013-10-01)

Aberrant ERK 1/2 complex activation and localization in scrapie-infected GT1-1 cells
by: Didonna Alessandro, et al.
Published: (2010-08-01)

Addendum to “Optimizing the success of cell transplantation therapy for stroke” [Neurobiol Dis. 37/2 (2010) 275–283]
by: Tonya M. Bliss, et al.
Published: (2010-06-01)

Corrigendum to “NCX1 and NCX3: Two new effectors of delayed preconditioning in brain ischemia” [Neurobiol. Dis. 45 (2012) 616–623]
by: Giuseppe Pignataro, et al.
Published: (2017-02-01)

Corrigendum to “Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus” [Neurobiol. Dis. 26/1 (2007) 174–188]
by: Owain W. Howell, et al.
Published: (2013-01-01)

Erratum to “Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice” [Neurobiol. Dis. 14 (2003) 318–327]
by: Jun Wang, et al.
Published: (2004-06-01)

Corrigendum to “Changes in serotoninergic and noradrenergic descending pain pathways during painful diabetic neuropathy: The preventive action of IGF1” [Neurobiol. Dis. 43/1 (2011) 275–284]
by: Carla Morgado, et al.
Published: (2012-02-01)

The nuclear structure of ^<151>Pm in the low excitation region＜1MeV
by: Seo, Takeshi
Published: (2017)

Créditos 15.1
by: Créditos 15.1
Published: (2012-11-01)

Corrigendum to “Expression of mutant DISC1 in Purkinje cells increases their spontaneous activity and impairs cognitive and social behaviors in mice” [Neurobiol. Dis. 103 (2017) 144–153]
by: Alexey V. Shevelkin, et al.
Published: (2017-12-01)

Erratum to “A novel path to chronic proprioceptive disability with oxaliplatin: Distortion of sensory encoding” [Neurobiol. Dis. 95 (2016) 54–65]
by: Jacob A. Vincent, et al.
Published: (2017-02-01)

Corrigendum to “Combined effects of prenatal inhibition of vasculogenesis and neurogenesis on rat brain development” [Neurobiol Dis. 32/3 (2009) 499–509]
by: Q.Y. Fan, et al.
Published: (2009-11-01)

Corrigendum to “Selective knockdown of mutant SOD1 in Schwann cells ameliorates disease in G85R mutant SOD1 transgenic mice” [Neurobiol. Dis. 48 (2012) 52–57]
by: Lijun Wang, et al.
Published: (2013-07-01)

Pharmacokinetics of quinacrine in the treatment of prion disease
by: Baldwin Michael, et al.
Published: (2004-11-01)

Corrigendum to “Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression” [Neurobiol. Dis. 19 (2005) 461–470]
by: Zhenfeng Xu, et al.
Published: (2008-08-01)

Corrigendum to “Prospects for mTOR-mediated functional repair after central nervous system trauma” [Neurobiol. Dis. 85 (2016) 99–110]
by: Martin Berry, et al.
Published: (2017-02-01)

Erratum to “Embryonic alteration of motoneuronal morphology induces hyperexcitability in the mouse model of amyotrophic lateral sclerosis” [Neurobiol. Dis. 54 (2013) 116–126]
by: Elodie Martin, et al.
Published: (2013-07-01)

Corrigendum to “Single chain variable fragment antibodies block aggregation and toxicity induced by familial ALS-linked mutant forms of SOD1” [Neurobiol. Dis. 56 (2013) 74–78]
by: Ghanashyam D. Ghadge, et al.
Published: (2013-10-01)

Corrigendum to “Characterization of a PLP-overexpressing transgenic rat, a model for the connatal form of Pelizaeus–Merzbacher disease” [Neurobiol. Dis. 44 (2) (2011) 231–238]
by: Joshua A. Mayer, et al.
Published: (2012-12-01)

Corrigendum to “Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease” [Neurobiol. Dis. 41/2 (2011) 508–527]
by: F. L'Episcopo, et al.
Published: (2011-06-01)

Corrigendum to “Transient muscarinic and glutamatergic stimulation of neural stem cells triggers acute and persistent changes in differentiation” [Neurobiol. Dis. 70 (2014) 252–261]
by: Ranmal A. Samarasinghe, et al.
Published: (2014-11-01)

Erratum to “Neonatal mice lacking functional Fas death receptors are resistant to hypoxic–ischemic brain injury” [Neurobiol. Dis. 17 (2004) 89–98]
by: Ernest M. Graham, et al.
Published: (2005-06-01)

Corrigendum to “Long-term seizure dynamics are determined by the nature of seizures and the mutual interactions between them” [Neurobiol. Dis., Volume 154 (2021), Article 105,347]
by: Jan Kudlacek, et al.
Published: (2021-11-01)

Corrigendum to “α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration” [Neurobiol. Dis., Volume 105 (2017) Article 84, 98]
by: Hisham Abdelmotilib, et al.
Published: (2021-11-01)

Corrigendum to “Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers” [Neurobiol. Dis. 83 (2015) 115–121]
by: Marios Politis, et al.
Published: (2017-02-01)

Corrigendum to “Spinocerebellar ataxia: miRNAs expose biological pathways underlying pervasive Purkinje cell degeneration” [Neurobiol. Dis. 2017 Dec 108 148–158]
by: Rogier van der Stijl, et al.
Published: (2018-08-01)

Corrigendum to “Human adult olfactory neural progenitors promote axotomized rubrospinal tract axonal reinnervation and locomotor recovery” [Neurobiol. Dis. 26 (2007) 363–374]
by: Ming Xiao, et al.
Published: (2007-08-01)

Candidate drug replacements for quinacrine in cutaneous lupus erythematosus
by: Victoria P Werth, et al.
Published: (2020-12-01)

Quinacrine in endometrial cancer| Repurposing an old antimalarial drug
by: Kalogera, Eleftheria
Published: (2016)

Corrigendum to “Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease” [Neurobiol Dis 52 (2013) 84–93]
by: Nicole M. Lewandowski, et al.
Published: (2013-06-01)

The role of EF-hand in calmodulin binding of voltage-gated Cav2.1 and Cav2.2 calcium channels
by: Soh, Daniel Hyeongjin
Published: (2018)

Corrigendum to “Neuron and neuroblast numbers and cytogenesis in the dentate gyrus of aged APPswe/PS1dE9transgenic mice: Effect of long-term treatment with paroxetine” [Neurobiol Dis. 2017; 104: 50–60]
by: LØ. Olesen, et al.
Published: (2019-04-01)

Enhanced Microdialysis Relative Recovery of Quinacrine by Using 1-Butyl-3-Methylimidazolium Halide Ionic Liquids
by: Shih-Chin Fu, et al.
Published: (2015)

Corrigendum to “Urokinase-type plasminogen activator regulates neurodegeneration and neurogenesis but not vascular changes in the mouse hippocampus after status epilepticus” [Neurobiol. Dis. 37/3 (2010) 692–703]
by: Laura Lahtinen, et al.
Published: (2011-01-01)

The use of cortisone as an adjunct to chloroquine and quinacrine in the treatment of avian malaria /
by: Wehrle, Louis
Published: (1969)

Continuous quinacrine treatment results in the formation of drug-resistant prions.
by: Sina Ghaemmaghami, et al.
Published: (2009-11-01)

Quinacrine Has Preferential Anticancer Effects on Mesothelioma Cells With Inactivating NF2 Mutations
by: Derek B. Oien, et al.
Published: (2021-09-01)

Neuronal junctophilins recruit specific CaV and RyR isoforms to ER-PM junctions and functionally alter CaV2.1 and CaV2.2
by: Stefano Perni, et al.
Published: (2021-03-01)